Scientific Reports,
Journal Year:
2023,
Volume and Issue:
13(1)
Published: Dec. 14, 2023
Abstract
Traumatic
brain
injury
(TBI)
is
a
major
cause
of
mortality
and
disability
worldwide,
particularly
among
individuals
under
the
age
45.
It
complex,
heterogeneous
disease
with
multifaceted
pathophysiology
that
remains
to
be
elucidated.
Metabolomics
has
potential
identify
metabolic
pathways
unique
biochemical
profiles
associated
TBI.
Herein,
we
employed
longitudinal
metabolomics
approach
study
TBI
in
weight
drop
mouse
model
reveal
changes
pathogenesis,
severity,
secondary
injury.
Using
proton
nuclear
magnetic
resonance
(
1
H
NMR)
spectroscopy,
biochemically
profiled
post-mortem
from
mice
suffered
mild
(N
=
25;
13
male
12
female),
severe
24;
11
female)
sham
controls
16;
5
at
baseline,
day
7
following
NMR-based
metabolomics,
combination
bioinformatic
analyses,
highlights
few
significant
metabolites
severity
perturbed
metabolism
related
We
report
concentrations
taurine
,
creatinine
adenine
dimethylamine
histidine
N-Acetyl
aspartate
glucose
1-phosphate
are
all
severity.
Longitudinal
observation
tissue
revealed
lead
distinct
profile
changes.
A
multi-class
was
able
classify
as
well
time
after
estimated
86%
accuracy.
Further,
identified
high
degree
correlation
between
respective
hemisphere
(r
>
0.84,
p
<
0.05,
Pearson
correlation).
This
underlying
While
comprehensive,
future
studies
should
investigate
whether:
(a)
highlighted
here
recapitulated
sufferers
(b)
if
panel
biomarkers
also
effective
less
invasively
harvested
biomatrices,
for
objective
rapid
identification
prognosis.
Signal Transduction and Targeted Therapy,
Journal Year:
2023,
Volume and Issue:
8(1)
Published: March 20, 2023
Metabolic
abnormalities
lead
to
the
dysfunction
of
metabolic
pathways
and
metabolite
accumulation
or
deficiency
which
is
well-recognized
hallmarks
diseases.
Metabolite
signatures
that
have
close
proximity
subject's
phenotypic
informative
dimension,
are
useful
for
predicting
diagnosis
prognosis
diseases
as
well
monitoring
treatments.
The
lack
early
biomarkers
could
poor
serious
outcomes.
Therefore,
noninvasive
methods
with
high
specificity
selectivity
desperately
needed.
Small
molecule
metabolites-based
metabolomics
has
become
a
specialized
tool
biomarker
pathway
analysis,
revealing
possible
mechanisms
human
various
deciphering
therapeutic
potentials.
It
help
identify
functional
related
variation
delineate
biochemical
changes
indicators
pathological
damage
prior
disease
development.
Recently,
scientists
established
large
number
profiles
reveal
underlying
networks
target
exploration
in
biomedicine.
This
review
summarized
analysis
on
potential
value
small-molecule
candidate
metabolites
clinical
events,
may
better
diagnosis,
prognosis,
drug
screening
treatment.
We
also
discuss
challenges
need
be
addressed
fuel
next
wave
breakthroughs.
Microbial Cell,
Journal Year:
2023,
Volume and Issue:
10(3), P. 49 - 62
Published: Feb. 24, 2023
Lactic
acid
bacteria
(LAB)
are
ubiquitous
microorganisms
that
can
colonize
the
intestine
and
participate
in
physiological
metabolism
of
host.
LAB
produce
a
variety
metabolites,
including
organic
acids,
bacteriocin,
amino
exopolysaccharides
vitamins.
These
metabolites
basis
function
have
profound
impact
on
host
health.
The
is
colonized
by
large
number
gut
with
high
species
diversity.
Metabolites
keep
balance
stability
microbiota
through
aiding
maintenance
intestinal
epithelial
barrier,
resisting
to
pathogens
regulating
immune
responses,
which
further
influence
nutrition,
behavior
In
this
review,
we
summarize
their
intestine.
We
also
discuss
underlying
regulatory
mechanisms
emphasize
link
between
human
from
perspective
health
promotion.
Gut Microbes,
Journal Year:
2024,
Volume and Issue:
16(1)
Published: Jan. 18, 2024
Trillions
of
microbes
live
symbiotically
in
the
host,
specifically
mucosal
tissues
such
as
gut.
Recent
advances
metagenomics
and
metabolomics
have
revealed
that
gut
microbiota
plays
a
critical
role
regulation
host
immunity
metabolism,
communicating
through
bidirectional
interactions
microbiota-gut-brain
axis
(MGBA).
The
regulates
both
systemic
contributes
to
neurodevelopment
behaviors
host.
With
aging,
composition
changes,
emerging
studies
linked
these
shifts
microbial
populations
age-related
neurological
diseases
(NDs).
Preclinical
demonstrated
microbiota-targeted
therapies
can
improve
behavioral
outcomes
by
modulating
microbial,
metabolomic,
immunological
profiles.
In
this
review,
we
discuss
pathways
brain-to-gut
or
gut-to-brain
signaling
summarize
metabolites
across
lifespan
disease.
We
highlight
recent
investigating
1)
changes
with
aging;
2)
how
aging
maternal
microbiome
affect
offspring
health;
3)
contribution
chronic
(e.g.,
Parkinson's
disease,
Alzheimer's
disease
cerebral
amyloidosis),
acute
brain
injury,
including
ischemic
stroke
traumatic
injury.
Journal of Neuroinflammation,
Journal Year:
2024,
Volume and Issue:
21(1)
Published: May 10, 2024
Abstract
Traumatic
brain
injury
(TBI)
is
a
chronic
and
debilitating
disease,
associated
with
high
risk
of
psychiatric
neurodegenerative
diseases.
Despite
significant
advancements
in
improving
outcomes,
the
lack
effective
treatments
underscore
urgent
need
for
innovative
therapeutic
strategies.
The
brain-gut
axis
has
emerged
as
crucial
bidirectional
pathway
connecting
gastrointestinal
(GI)
system
through
an
intricate
network
neuronal,
hormonal,
immunological
pathways.
Four
main
pathways
are
primarily
implicated
this
crosstalk,
including
systemic
immune
system,
autonomic
enteric
nervous
systems,
neuroendocrine
microbiome.
TBI
induces
profound
changes
gut,
initiating
unrestrained
vicious
cycle
that
exacerbates
axis.
Alterations
gut
include
mucosal
damage
malabsorption
nutrients/electrolytes,
disintegration
intestinal
barrier,
increased
infiltration
cells,
dysmotility,
dysbiosis,
enteroendocrine
cell
(EEC)
dysfunction
disruption
(ENS)
(ANS).
Collectively,
these
further
contribute
to
neuroinflammation
neurodegeneration
via
gut-brain
In
review
article,
we
elucidate
roles
various
anti-inflammatory
pharmacotherapies
capable
attenuating
dysregulated
inflammatory
response
along
TBI.
These
agents
hormones
such
serotonin,
ghrelin,
progesterone,
ANS
regulators
beta-blockers,
lipid-lowering
drugs
like
statins,
flora
modulators
probiotics
antibiotics.
They
attenuate
by
targeting
distinct
both
post-TBI.
exhibit
promising
potential
mitigating
inflammation
enhancing
neurocognitive
outcomes
patients.
Antioxidants,
Journal Year:
2024,
Volume and Issue:
13(3), P. 303 - 303
Published: Feb. 29, 2024
Traumatic
brain
injury
(TBI)
is
a
major
global
health
problem
that
affects
both
civilian
and
military
populations
worldwide.
Post-injury
acute,
sub-acute,
chronic
progression
of
secondary
processes
may
contribute
further
to
other
neurodegenerative
diseases.
However,
there
are
no
approved
therapeutic
options
available
can
attenuate
TBI-related
progressive
pathophysiology.
Recent
advances
in
preclinical
research
have
identified
mitochondria-centric
redox
imbalance,
bioenergetics
failure
calcium
dysregulation
play
crucial
role
after
TBI.
Mitochondrial
antioxidants
an
important
regulating
homeostasis.
Based
on
the
proven
efficacy
clinical
compounds
targeting
numerous
pathways
trigger
innate
antioxidant
defense,
we
be
able
alleviate
TBI
pathology
by
primarily
focusing
preserving
post-injury
mitochondrial
cerebral
function.
In
this
review,
will
discuss
novel
mitochondria-targeted
compounds,
which
offer
high
capability
successful
translation
for
management
near
future.
European Journal of Neuroscience,
Journal Year:
2022,
Volume and Issue:
57(2), P. 400 - 418
Published: Dec. 10, 2022
Traumatic
brain
injury
(TBI)
can
be
a
devastating
and
debilitating
disease
to
endure.
Due
improvements
in
clinical
practice,
declining
mortality
rates
have
led
research
into
the
long-term
consequences
of
TBI.
For
example,
incidence
severity
TBI
been
associated
with
an
increased
susceptibility
developing
neurodegenerative
disorders,
such
as
Parkinson's
or
Alzheimer's
disease.
However,
mechanisms
linking
this
alarming
association
are
yet
fully
understood.
Recently,
there
has
groundswell
evidence
implicating
microbiota-gut-brain
axis
pathogenesis
these
diseases.
Interestingly,
survivors
often
report
gastrointestinal
complaints
animal
studies
demonstrated
dysfunction
dysbiosis
following
injury.
Autonomic
dysregulation
chronic
inflammation
appear
main
driver
pathologies.
Consequently,
review
will
explore
potential
role
development
diseases
Microorganisms,
Journal Year:
2023,
Volume and Issue:
11(8), P. 1990 - 1990
Published: Aug. 2, 2023
The
intestinal
microbiome
plays
a
critical
role
in
host
immune
function
and
homeostasis.
Patients
suffering
from—as
well
as
models
representing—multiple
traumatic
injuries,
isolated
organ
system
trauma,
various
severities
of
injury
have
been
studied
an
area
interest
the
dysregulation
systemic
inflammation
which
occur
after
trauma.
These
studies
also
demonstrate
changes
gut
diversity
even
microbial
composition,
with
transition
to
pathobiome
state.
In
addition,
sex
has
identified
biological
variable
influencing
alterations
Therapeutics
such
fecal
transplantation
utilized
ameliorate
not
only
these
but
may
play
recovery
postinjury.
This
review
summarizes
that
postinjury,
either
or
multiple
along
proposed
mechanisms
for
future
directions
field.